105 related articles for article (PubMed ID: 24988251)
1. Functional and structural characterization of 2-amino-4-phenylthiazole inhibitors of the HIV-1 nucleocapsid protein with antiviral activity.
Mori M; Nucci A; Lang MC; Humbert N; Boudier C; Debaene F; Sanglier-Cianferani S; Catala M; Schult-Dietrich P; Dietrich U; Tisné C; Mely Y; Botta M
ACS Chem Biol; 2014 Sep; 9(9):1950-5. PubMed ID: 24988251
[TBL] [Abstract][Full Text] [Related]
2. Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains.
Mori M; Kovalenko L; Malancona S; Saladini F; De Forni D; Pires M; Humbert N; Real E; Botzanowski T; Cianférani S; Giannini A; Dasso Lang MC; Cugia G; Poddesu B; Lori F; Zazzi M; Harper S; Summa V; Mely Y; Botta M
ACS Chem Biol; 2018 Jan; 13(1):253-266. PubMed ID: 29235845
[TBL] [Abstract][Full Text] [Related]
3. (Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity.
Humbert N; Kovalenko L; Saladini F; Giannini A; Pires M; Botzanowski T; Cherenok S; Boudier C; Sharma KK; Real E; Zaporozhets OA; Cianférani S; Seguin-Devaux C; Poggialini F; Botta M; Zazzi M; Kalchenko VI; Mori M; Mély Y
ACS Infect Dis; 2020 Apr; 6(4):687-702. PubMed ID: 32045204
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory Effect of Lithospermic Acid on the HIV-1 Nucleocapsid Protein.
Mori M; Ciaco S; Mély Y; Karioti A
Molecules; 2020 Nov; 25(22):. PubMed ID: 33233563
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of a new type of inhibitor against the human immunodeficiency virus type-1 nucleocapsid protein.
Kim MJ; Kim SH; Park JA; Yu KL; Jang SI; Kim BS; Lee ES; You JC
Retrovirology; 2015 Nov; 12():90. PubMed ID: 26545586
[TBL] [Abstract][Full Text] [Related]
6. Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1.
Mori M; Kovalenko L; Lyonnais S; Antaki D; Torbett BE; Botta M; Mirambeau G; Mély Y
Curr Top Microbiol Immunol; 2015; 389():53-92. PubMed ID: 25749978
[TBL] [Abstract][Full Text] [Related]
7. Use of virtual screening for discovering antiretroviral compounds interacting with the HIV-1 nucleocapsid protein.
Mori M; Schult-Dietrich P; Szafarowicz B; Humbert N; Debaene F; Sanglier-Cianferani S; Dietrich U; Mély Y; Botta M
Virus Res; 2012 Nov; 169(2):377-87. PubMed ID: 22634301
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel 2-benzoxazolinone derivatives with specific inhibitory activity against the HIV-1 nucleocapsid protein.
Gamba E; Mori M; Kovalenko L; Giannini A; Sosic A; Saladini F; Fabris D; Mély Y; Gatto B; Botta M
Eur J Med Chem; 2018 Feb; 145():154-164. PubMed ID: 29324338
[TBL] [Abstract][Full Text] [Related]
9. Identification by high throughput screening of small compounds inhibiting the nucleic acid destabilization activity of the HIV-1 nucleocapsid protein.
Shvadchak V; Sanglier S; Rocle S; Villa P; Haiech J; Hibert M; Van Dorsselaer A; Mély Y; de Rocquigny H
Biochimie; 2009 Jul; 91(7):916-23. PubMed ID: 19401213
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in Vitro Screening of New Series of 2,6-Dipeptidyl-anthraquinones: Influence of Side Chain Length on HIV-1 Nucleocapsid Inhibitors.
Frecentese F; Sosic A; Saccone I; Gamba E; Link K; Miola A; Cappellini M; Cattelan MG; Severino B; Fiorino F; Magli E; Corvino A; Perissutti E; Fabris D; Gatto B; Caliendo G; Santagada V
J Med Chem; 2016 Mar; 59(5):1914-24. PubMed ID: 26797100
[TBL] [Abstract][Full Text] [Related]
11. Targeting the viral nucleocapsid protein in anti-HIV-1 therapy.
de Rocquigny H; Shvadchak V; Avilov S; Dong CZ; Dietrich U; Darlix JL; Mély Y
Mini Rev Med Chem; 2008 Jan; 8(1):24-35. PubMed ID: 18220982
[TBL] [Abstract][Full Text] [Related]
12. Rationally Designed Peptides as Efficient Inhibitors of Nucleic Acid Chaperone Activity of HIV-1 Nucleocapsid Protein.
Shvadchak V; Zgheib S; Basta B; Humbert N; Langedijk J; Morris MC; Ciaco S; Maskri O; Darlix JL; Mauffret O; Fossé P; Réal E; Mély Y
Biochemistry; 2018 Jul; 57(30):4562-4573. PubMed ID: 30019894
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Substituted 1,2,3-Dithiazoles as Inhibitors of the Feline Immunodeficiency Virus (FIV) Nucleocapsid Protein via a Proposed Zinc Ejection Mechanism.
Asquith CR; Konstantinova LS; Laitinen T; Meli ML; Poso A; Rakitin OA; Hofmann-Lehmann R; Hilton ST
ChemMedChem; 2016 Oct; 11(19):2119-2126. PubMed ID: 27511289
[TBL] [Abstract][Full Text] [Related]
14. A tryptophan-rich hexapeptide inhibits nucleic acid destabilization chaperoned by the HIV-1 nucleocapsid protein.
Raja C; Ferner J; Dietrich U; Avilov S; Ficheux D; Darlix JL; de Rocquigny H; Schwalbe H; Mély Y
Biochemistry; 2006 Aug; 45(30):9254-65. PubMed ID: 16866372
[TBL] [Abstract][Full Text] [Related]
15. Discovery and structural characterization of a new inhibitor series of HIV-1 nucleocapsid function: NMR solution structure determination of a ternary complex involving a 2:1 inhibitor/NC stoichiometry.
Goudreau N; Hucke O; Faucher AM; Grand-Maître C; Lepage O; Bonneau PR; Mason SW; Titolo S
J Mol Biol; 2013 Jun; 425(11):1982-1998. PubMed ID: 23485336
[TBL] [Abstract][Full Text] [Related]
16. Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy.
Garg D; Torbett BE
Virus Res; 2014 Nov; 193():135-43. PubMed ID: 25026536
[TBL] [Abstract][Full Text] [Related]
17. 2,2'-Dithiobisbenzamides and 2-benzisothiazolones, two new classes of antiretroviral agents: SAR and mechanistic considerations.
Domagala JM; Gogliotti R; Sanchez JP; Stier MA; Musa K; Song Y; Loo J; Reily M; Tummino P; Harvey P; Hupe D; Sharmeen L; Mack D; Scholten J; Saunders J; McQuade T
Drug Des Discov; 1997 May; 15(1):49-61. PubMed ID: 9332831
[TBL] [Abstract][Full Text] [Related]
18. Selection and stabilization of the RNA aptamers against the human immunodeficiency virus type-1 nucleocapsid protein.
Kim SJ; Kim MY; Lee JH; You JC; Jeong S
Biochem Biophys Res Commun; 2002 Mar; 291(4):925-31. PubMed ID: 11866454
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles.
Roth T; Morningstar ML; Boyer PL; Hughes SH; Buckheit RW; Michejda CJ
J Med Chem; 1997 Dec; 40(26):4199-207. PubMed ID: 9435891
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of distal and proximal fleximer base analogues and evaluation in the nucleocapsid protein of HIV-1.
Ku T; Lopresti N; Shirley M; Mori M; Marchant J; Heng X; Botta M; Summers MF; Seley-Radtke KL
Bioorg Med Chem; 2019 Jul; 27(13):2883-2892. PubMed ID: 31126822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
